Alex is a pediatrician by training, with years of clinical experience in pediatric rheumatology, immunology, and rare diseases including lysosomal storage diseases in particular. He has longstanding relationships with international physician colleagues and patient organizations in these fields. Alex most recently served as the global medical lead for Plexcera Therapeutics, helping build the Farber disease program as well as guiding a second program aimed at treatment of bone and joint disease in mucopolysaccharidosis through a Phase I trial. Alex has lived in the US, Hungary and Germany, and is currently based out of Basel, Switzerland. Before studying medicine, Alex finished a degree in the cultural anthropology of religion and cared for an orchard of 40 fruit trees.